Clinical experience with steroid-eluting unipolar electrodes.
In continuing search of low chronic threshold leads, a new concept of electrode design which is capable of delivering corticosteroids at the myocardial tissue interface has been made available by Medtronic. Twenty-three patients, 17 females and 6 males, were either implanted with 4003 (n = 21) or 5023 (n = 2) steroid-eluting electrodes in the ventricular chamber. Pacing modes utilized were VVIM (n = 13) or DDD (n = 10). Pulse generators used were Medtronic (7005, 8317, 8329) Pacesetter (285) and Intermedics (283). Thresholds at the time of implantation at 0.50 msec pulse width were 0.40 +/- 0.02 volts at 0.66 +/- 0.05 milliamps. Resistance and R wave measured were 565.43 +/- 22.07 ohms and 9.24 +/- 1.06 mv, respectively. Chronic thresholds were checked on routine follow-up visits by either decreasing pulse width and/or pulse amplitude. Data is being reported between 1 and 88 (23.22 +/- 4.35) weeks. Pulse width threshold at 2.5 volts were 0.10 msec (n = 11) and 0.05 msec or lower (n = 12). At 5.0 volts no loss of capture was seen at 0.05 msec (n = 22) except in one patient at 0.10 msec. Pulse width thresholds in the first 24 weeks were lower than 0.20 msec at 2.5 volts (n = 15) and less than 0.70 msec. at 0.8 volts (n = 6). No loss of sensing was seen by electrocardiographic analysis at the time of threshold checks with the pulse generator at standard setting of the R wave. Thus, in this initial report, the steroid-eluting electrodes have demonstrated very low thresholds both in the early and chronic follow-up phase.(ABSTRACT TRUNCATED AT 250 WORDS)
Pirzada
F A
FA
Department of Cardiology, Malden Hospital, Boston University School of Medicine, Massachusetts 02148.
Moschitto
L J
LJ
Diorio
D
D
D003907:Dexamethasone; D011211:Electric Power Supplies; D004567:Electrodes, Implanted; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial
D003907:Dexamethasone